Expert Review of Clinical Immunology Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps. By , 1 year ago
Expert Review of Clinical Immunology Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease. By Philip J. Smith, 1 year ago
Expert Review of Clinical Immunology Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook. By , 1 year ago
Expert Review of Clinical Immunology Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook. By Koshiro Sonomoto, 1 year ago
Expert Review of Clinical Immunology Correction. By tandf: Expert Review of Clinical Immunology: Table of Contents, 1 year ago
Expert Review of Clinical Immunology Correction. By tandf: Expert Review of Clinical Immunology: Table of Contents, 1 year ago
Expert Review of Clinical Immunology COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?. By , 1 year ago
Expert Review of Clinical Immunology COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?. By L. Klimek, 1 year ago
Expert Review of Clinical Immunology T-lymphocyte depleted transplants for inborn errors of immunity. By MA Slatter, 1 year ago
Expert Review of Clinical Immunology T-lymphocyte depleted transplants for inborn errors of immunity. By , 1 year ago